about
Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutationsDNA copy number gains in malignant pleural mesotheliomaFeasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001.Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells.The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cellsActive Secretion of Dimerized S100A11 Induced by the Peroxisome in Mesothelioma Cells.Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib.Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterations.Establishment and molecular characterization of cell lines from Japanese patients with malignant pleural mesothelioma.Genetic alterations in lung adenocarcinoma with a micropapillary componentThe proliferative effects of asbestos-exposed peripheral blood mononuclear cells on mesothelial cells.Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway.Drug resistance to EGFR tyrosine kinase inhibitors for non-small cell lung cancer.Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact.Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies.Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients.Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.Usefulness of Thoracoscopic Debridement for Chronic Empyema after an Extrapleural Pneumonectomy.Early postoperative complications after middle lobe-preserving surgery for secondary lung cancer.The Feasibility of Median Sternotomy With or Without Thoracotomy for Locally Advanced Non-Small Cell Lung Cancer Treated With Induction Chemoradiotherapy.Estimation of age-related DNA degradation from formalin-fixed and paraffin-embedded tissue according to the extraction methodsElacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features.Is tumor location an independent prognostic factor in locally advanced non-small cell lung cancer treated with trimodality therapy?Massive subcutaneous and mediastinal emphysema with little pneumothorax treated by surgery after pulmonary radiofrequency ablation.Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma.Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients.Restrictive ventilatory impairment is associated with poor outcome in patients with cT1aN0M0 peripheral squamous cell carcinoma of the lung.Induction chemoradiotherapy using docetaxel and cisplatin with definitive-dose radiation followed by surgery for locally advanced non-small cell lung cancer.Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma.Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery.Effects of Cold Ischemia on RNA Stability and Quality of Lung Tissues Based on Standard PREanalytical Code Categorization.Diagnostic Value of Dual-time-point F-18 FDG PET/CT and Chest CT for the Prediction of Thymic Epithelial Neoplasms.Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer.Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.
P50
Q28384015-494A810B-998C-41BA-81A5-CC0CA2ED92F7Q28395184-F9D6D268-4F6E-4D1B-A734-B3A4BC241CBDQ33437409-3B0D8B9F-1BDE-43F1-BE59-A756B8518D4BQ33510334-C52D105E-0983-4AC5-97C7-ADAC1682F7F3Q34048154-967D2576-0116-4E7E-9535-D6015921687CQ36059247-736F068B-438B-415F-A78B-8AF9CB2FC82AQ36262907-B6DD6BE9-5D1F-4615-869F-A356EC8BCF75Q36269777-2F6BAEB3-ACFE-49E3-967E-31942BF364AEQ36495936-5104D564-07EA-434A-B496-E7E7BDF7ECF6Q36503271-D413B52D-FA97-422E-928A-F4128DD7DB01Q36524569-43E1F02F-C088-45BE-B553-80106EFC4833Q36825187-9C6E6BFE-D396-4988-BCE1-C86CC5019745Q37260026-E6A2B46E-FA36-417F-8B54-974BDB198A90Q37529089-D2769048-55B9-4623-AB67-F929C242D464Q38241984-1F7D84AB-760C-4966-8A4B-022BF1CB8AA2Q38542766-4AAFA672-16D5-4CA3-A34C-DB512D5225F1Q38707882-209B55A6-4F8B-4D41-85E6-D3B6BF146790Q38724575-D7595174-DC60-48DA-8942-B2DA02312820Q39172872-27A22CFD-5768-4350-B60E-E7791D26F38FQ39524618-03A093D6-ACEC-4FED-958D-560864385053Q40399725-2957F687-B831-434E-B8F0-CA6B747B1A12Q40540242-7BD06356-09D0-4B5C-9A42-38A901E90344Q40718648-564326D1-03A1-4895-A8A4-9DAE3C3676E9Q41672200-BD054AD9-08F6-4812-9B61-621BE1B1D952Q41676866-63F7577C-A435-474B-9BBE-0FCC94F656EEQ41830456-4F82F29A-754E-4156-8EA1-C6F0F30353ACQ42340612-40DD1BA5-1213-4529-9568-F43FA543379BQ45099359-76199377-7564-4DC4-B122-AF96AC2BD776Q45272652-3625ADE4-3960-4563-811B-A1C47B8909B7Q45333939-0D1FCFEB-52BC-46BB-8C70-9377F53AD562Q47125015-346A45BB-7FF8-498E-AD5A-9E37F7CB2EBCQ47129111-1BDE2537-85AB-4A32-992C-22A8C883B0D6Q48181383-1B78DB03-0B16-44BB-B953-A1CC48439C66Q49710712-24A26933-11A6-43D9-896C-8C9D474F448FQ50058205-CBEE0C17-F549-4535-8277-540BD635856DQ50093435-7DF67839-E288-413F-BC54-418A054E1718Q50718531-EC712E28-811D-42C8-A6A8-9C10D1DDE74CQ52652871-08A89A63-2D50-423F-BBF3-33B5A585C591Q52728849-D92DE835-6468-4F35-9173-7782E47AD0FBQ53702598-FC8D84AC-F4C1-458B-81E7-C722B0E1D293
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-8532-7915
@en
name
Junichi Soh
@ast
Junichi Soh
@en
Junichi Soh
@es
Junichi Soh
@nl
type
label
Junichi Soh
@ast
Junichi Soh
@en
Junichi Soh
@es
Junichi Soh
@nl
prefLabel
Junichi Soh
@ast
Junichi Soh
@en
Junichi Soh
@es
Junichi Soh
@nl
P106
P31
P496
0000-0001-8532-7915